BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 36917657)

  • 1. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
    Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
    Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-on-a-Chip for Cancer and Immune Organs Modeling.
    Sun W; Luo Z; Lee J; Kim HJ; Lee K; Tebon P; Feng Y; Dokmeci MR; Sengupta S; Khademhosseini A
    Adv Healthc Mater; 2019 Feb; 8(4):e1801363. PubMed ID: 30605261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues.
    Hwangbo H; Chae S; Kim W; Jo S; Kim GH
    Theranostics; 2024; 14(1):33-55. PubMed ID: 38164155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spheroids to organoids: Solid cancer models for anticancer drug discovery].
    Alzeeb G; Corcos L; Le Jossic-Corcos C
    Bull Cancer; 2022 Jan; 109(1):49-57. PubMed ID: 34848046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling neoplastic disease with spheroids and organoids.
    Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
    J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent research advances of the biomimetic tumor microenvironment and regulatory factors on microfluidic devices: A systematic review.
    Xu H; Cheng C; Le W
    Electrophoresis; 2022 Apr; 43(7-8):839-847. PubMed ID: 35179796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-on-Chip platforms to study tumor evolution and chemosensitivity.
    Dsouza VL; Kuthethur R; Kabekkodu SP; Chakrabarty S
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188717. PubMed ID: 35304293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
    Pyo DH; Hong HK; Lee WY; Cho YB
    Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review.
    Kim S; Lam PY; Jayaraman A; Han A
    Biomed Microdevices; 2024 May; 26(2):26. PubMed ID: 38806765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension.
    Miserocchi G; Bocchini M; Cortesi M; Arienti C; De Vita A; Liverani C; Mercatali L; Bravaccini S; Ulivi P; Zanoni M
    Front Immunol; 2023; 14():1171141. PubMed ID: 37033986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
    Ferreira LP; Gaspar VM; Mano JF
    Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in three-dimensional tumor models for colorectal cancer].
    Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
    Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
    Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in cancer modeling: fluidic systems for increasing representativeness of large 3D multicellular spheroids.
    Piccinini F; Santis I; Bevilacqua A
    Biotechniques; 2018 Dec; 65(6):312-314. PubMed ID: 30477324
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures.
    Wieleba I; Wojas-Krawczyk K; Krawczyk P; Milanowski J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic cell culture for cell adhesive propagation for tissue engineering strategies.
    Luo Q; Shang K; Zhu J; Wu Z; Cao T; Ahmed AAQ; Huang C; Xiao L
    Mater Horiz; 2023 Oct; 10(11):4662-4685. PubMed ID: 37705440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies.
    Prince E; Kheiri S; Wang Y; Xu F; Cruickshank J; Topolskaia V; Tao H; Young EWK; McGuigan AP; Cescon DW; Kumacheva E
    Adv Healthc Mater; 2022 Jan; 11(1):e2101085. PubMed ID: 34636180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.